Lincoln Pharmaceuticals Limited (BOM:531633)
India · Delayed Price · Currency is INR 590.40
-5.20 (-0.87%)
At close: Sep 25, 2026
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 11.83 billion as of September 25, 2026. Its market cap has increased by 8.16% in one year.
Market Cap
11.83B
Enterprise Value
9.46B
Revenue
6.94B
Ranking
n/a
PE Ratio
12.26
Stock Price
590.40
ChartMarket Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 11.83B, an increase of 8,413.42%. That is a compound annual growth rate of 22.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 11.83B | 22.19% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syncom Formulations (India) | 18.86B |
| Amrutanjan Health Care | 14.63B |
| TTK Healthcare | 14.57B |
| Kopran | 13.75B |
| Fermenta Biotech | 13.42B |
| Bharat Parenterals | 13.06B |
| Sudarshan Pharma Industries | 9.80B |
| Anuh Pharma | 9.05B |